-
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells
Bergonzini, C., Gregori, A., Hagens, T. M. S., van der Noord, V. E., van de Water, B., Zweemer, A. J. M., Coban, B., Capula, M., Mantini, G., Botto, A., Finamore, F., Garajova, I., McDonnell, L. A., Schmidt, T., Giovannetti, E. & Danen, E. H. J., 1 Dec 2024, In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 43, 1, 4.Research output: Contribution to journal › Article* › Academic › peer-review
-
Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel
Gregori, A., Bergonzini, C., Capula, M., de Mercado, R. R., Danen, E. H. J., Giovannetti, E. & Schmidt, T., 1 Nov 2024, In: Cancers. 16, 22, 3863.Research output: Contribution to journal › Article* › Academic › peer-review
-
Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems
Lencioni, G., Gregori, A., Toledo, B., Rebelo, R., Immordino, B., Amrutkar, M., Xavier, C. P. R., Kocijančič, A., Pandey, D. P., Perán, M., Castaño, J. P., Walsh, N. & Giovannetti, E., 1 Nov 2024, In: Seminars in Cancer Biology. 106-107, p. 217-233 17 p.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications